AUTOLOGOUS STEM CELL MOBILISATION AND -TRANSPLANTATION IN PAEDIATRIC ONCOLOGY; POOR MOBILIZERS, PLERIXAFOR AND PEGFILGRASTIM

被引:0
|
作者
Hochheuser, Caroline [1 ,2 ]
Rozeman, Maria [1 ]
Kunze, Nina [2 ]
Gelineau, Nina [1 ,3 ]
Kuijk, Carlijn [2 ]
Jaspers-Bakkers, Antoinette [1 ]
Van Den Bos, Cor [4 ]
Slager, Tirza [5 ]
Zsiros, Jozsef [1 ]
Tissing, Wim [6 ,7 ]
Westinga, Kasper [8 ]
Zwaan, C. Michel
Voermans, Carlijn [2 ]
Tytgat, Lieve [1 ]
Kraal, K. C. J. M. [1 ]
Timmerman, Ilse [1 ,2 ]
机构
[1] Prinses Maxima Centrum, Solid Tumors, Utrecht, Netherlands
[2] Univ Amsterdam, Dept Hematopoiesis, Sanquin Res & Landsteiner Lab, Amsterdam, Netherlands
[3] Univ Amsterdam, Dept Expt Immunohematol, Acad Med Ctr Amsterdam, Sanquin Res & Landsteiner Lab, Amsterdam, Netherlands
[4] Prinses Maxima Ctr Pediat Oncol, Haematooncol, Utrecht, Netherlands
[5] Erasmus MC, Rotterdam, Netherlands
[6] Princess Maxima Ctr Pediat Oncol, Support Care, Utrecht, Netherlands
[7] Univ Med Ctr Groningen, Dept Pediat Oncol Hematol, Groningen, Netherlands
[8] Univ Med Ctr Utrecht, Dept Clin Pharm, Cell Therapy Facil, Utrecht, Netherlands
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
O296
引用
收藏
页数:2
相关论文
共 50 条
  • [41] The role of plerixafor in optimizing peripheral blood stem cell mobilization for autologous stem cell transplantation
    Mohty, M.
    Duarte, R. F.
    Croockewit, S.
    Huebel, K.
    Kvalheim, G.
    Russell, N.
    LEUKEMIA, 2011, 25 (01) : 1 - 6
  • [42] Plerixafor (AMD3100) for stem cell mobilization: once dosing in poor mobilizers: Efficacious and economically feasible?
    Fink, G.
    Kleber, M.
    Scherer, E.
    Gross, B.
    Mueller-Schmah, C.
    Duyster, J.
    Waesch, R.
    Engelhardt, M.
    ONKOLOGIE, 2013, 36 : 236 - 237
  • [43] Preemptive dosing of plerixafor given to poor stem cell mobilizers on day 5 of G-CSF administration
    Horwitz, M. E.
    Chute, J. P.
    Gasparetto, C.
    Long, G. D.
    McDonald, C.
    Morris, A.
    Rizzieri, D. A.
    Sullivan, K. M.
    Chao, N. J.
    BONE MARROW TRANSPLANTATION, 2012, 47 (08) : 1051 - 1055
  • [44] The role of plerixafor in optimizing peripheral blood stem cell mobilization for autologous stem cell transplantation
    M Mohty
    R F Duarte
    S Croockewit
    K Hübel
    G Kvalheim
    N Russell
    Leukemia, 2011, 25 : 1 - 6
  • [45] Engraftment and outcome after asct with plerixafor-mobilzed stem cells in poor mobilizers
    Angelova, O.
    Ditlbacher, A.
    Schmidt, S.
    Nachbaur, D.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 248 - 248
  • [46] Pegfilgrastim in Autologous Stem Cell Transplant
    Relias, Valerie
    Lyons, Nancy
    Sprague, Kellie A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S456 - S457
  • [47] Stem Cell Mobilization in Poor Mobilizers Using Plerixafor and G-CSF with or without Chemotherapy: A European Perspective
    Fresen, Maximilian M.
    Duarte, Rafael F.
    Apperley, Jane F.
    Basak, Grzegorz
    Douglas, Kenneth W.
    Gabriel, Ian H.
    Geraldes, Catarina
    Jaksic, Ozren
    Koristek, Zdenek
    Kroeger, Nicolaus
    Lanza, Francesco
    Lemoli, Roberto M.
    Mikala, Gabor
    Selleslag, Dominik
    Worel, Nina
    Lange, Florian
    Mohty, Mohamad
    Hubel, Kai
    BLOOD, 2011, 118 (21) : 1289 - 1290
  • [48] Preemptive dosing of plerixafor given to poor stem cell mobilizers on day 5 of G-CSF administration
    M E Horwitz
    J P Chute
    C Gasparetto
    G D Long
    C McDonald
    A Morris
    D A Rizzieri
    K M Sullivan
    N J Chao
    Bone Marrow Transplantation, 2012, 47 : 1051 - 1055
  • [49] ENGRAFTMENT AND OUTCOME AFTER ASCT WITH PLERIXAFOR-MOBILZED STEM CELLS IN POOR MOBILIZERS
    Nachbaur, D.
    Angelova, O.
    Ditlbacher, A.
    Schmidt, S.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S227 - S228
  • [50] Plerixafor and Granulocyte Colony-Stimulating Factor for Poor Mobilizers in Patients Undergoing Autologous Peripheral Hematopoietic Stem Cell Transplant: Single-Institution Study
    El Warrak, Samantha
    Timonian, Michael Anthony
    Mohty, Razan
    Ismail, Fatima
    Zahreddine, Ammar
    Kreidieh, Nabila
    Abou Dalle, Iman
    Bazarbachi, Ali
    El Cheikh, Jean
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S440 - S441